v3.23.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Apr. 30, 2023
Apr. 30, 2022
Jan. 31, 2023
Operating activities:      
Net loss $ (412) $ (25,839) $ (65,938)
Adjustments to reconcile net loss to net cash provided by operating activities:      
Depreciation and amortization expense 4,668 4,387  
Bad debt expense 975 (650)  
Stock-based compensation expense 11,012 18,086  
Amortization of operating lease right-of-use assets 2,293 2,370  
Other, net 100 302  
Changes in operating assets and liabilities:      
Accounts receivable 50,614 42,680  
Prepaid expenses and other current assets (1,657) (5,685)  
Costs to obtain revenue contracts 3,329 4,383  
Other long term assets 1,094 678  
Accounts payable, accrued expenses and other current liabilities (15,047) 4,987  
Unearned revenue (27,337) (24,519)  
Operating lease liabilities (2,904) (3,151)  
Other long term liabilities 16 (168)  
Net cash provided by operating activities 26,744 17,861  
Investing activities:      
Capital expenditures (944) (1,644)  
Net cash used in investing activities (944) (1,644)  
Financing activities:      
Proceeds from exercise of stock options 7,271 311  
Repurchase of common stock (4,583) (27,142)  
Payments for taxes related to net share settlement of stock-based compensation awards (3,237) 0  
Payments of deferred financing costs (64) (68)  
Proceeds, net from employee stock purchase plan withholdings 925 606  
Net cash provided by (used in) financing activities 312 (26,293)  
Effect of exchange rate changes on cash and cash equivalents 524 (3,365)  
Net increase (decrease) in cash and cash equivalents 26,636 (13,441)  
Cash and cash equivalents at beginning of period 190,214 261,210 261,210
Cash and cash equivalents at end of period $ 216,850 $ 247,769 $ 190,214

Source

HTML PDF
ZIP